Skip to main content
. Author manuscript; available in PMC: 2014 Aug 8.
Published in final edited form as: Toxicol Appl Pharmacol. 2011 Aug 7;256(2):154–167. doi: 10.1016/j.taap.2011.08.002

Table 2.

Functional categorization and potential response element regulation of select hepatic genes differentially expressed by 30 μg/kg TCDD, 300 mg/kg PCB153, and MIX.

Functional category Gene ID Gene name Gene symbol TCDD* PCB153* MIX* DREsa PXREsa CAREsa
11761 Aldehyde oxidase 1 Aox1 2.2 2.9 4.8 yes yes yes
11997 Aldo-keto reductase family 1, member B7 Akr1b7 NC 22.1 16.8 yes yes yes
432720 Aldo-keto reductase family 1, member C19 Akr1c19 NC 1.7 2.0 yes yes no
116852 Aldo-keto reductase family 1, member C20 Akr1c20 −1.7 −1.6 −3.0 no yes no
Xenobiotic metabolism/Oxidoreductase activity/Oxidative stress 13076 Cytochrome P450, family 1, subfamily a, polypeptide 1 Cyp1a1 348.1 NC 348.2 yes yes yes
13077 Cytochrome P450, family 1, subfamily a, polypeptide 2 Cyp1a2 2.4 1.7 2.4 yes yes yes
13088 Cytochrome P450, family 2, subfamily b, polypeptide 10 Cyp2b10 NC 16.1 24.2 yes yes yes
13089 Cytochrome P450, family 2, subfamily b, polypeptide 13 Cyp2b13 NC 1.9 1.9 yes yes yes
13094 Cytochrome P450, family 2, subfamily b, polypeptide 9 Cyp2b9 NC 7.6 6.2 no yes yes
72082 Cytochrome P450, family 2, subfamily c, polypeptide 55 Cyp2c55 NC 48.4 48.4 yes yes yes
13112 Cytochrome P450, family 3, subfamily a, polypeptide 11 Cyp3a11b −1.9 4.0 3.1 yes yes yes
13113 Cytochrome P450, family 3, subfamily a, polypeptide 13 Cyp3a13 −1.9 2.5 NC no yes no
56388 Cytochrome P450, family 3, subfamily a, polypeptide 25 Cyp3a25 NC 3.8 3.0 no yes yes
56050 Cytochrome P450, family 39, subfamily a, polypeptide 1 Cyp39a1 NC 2.5 2.0 yes yes no
14776 Glutathione peroxidase 2 Gpx2 NC 4.3 8.9 yes yes yes
14858 Glutathione S-transferase, alpha 2 (Yc2) Gsta2 5.8 4.1 11.3 yes yes yes
14863 Glutathione S-transferase, mu 2 Gstm2 2.0 2.0 2.2 yes yes yes
14865 Glutathione S-transferase, mu 4 Gstm4 2.4 4.0 5.6 yes yes yes
14872 Glutathione S-transferase, theta 2 Gstt2 2.0 2.0 2.2 yes yes yes
18104 NAD(P)H dehydrogenase, quinone 1 Nqo1s 4.6 2.8 12.6 yes yes yes
76650 Sulfiredoxin 1 homolog (S. cerevisiae) Srxn1s 2.6 2.3 3.9 yes yes yes
394435 UDP glucuronosyltransferase 1 family, polypeptide A6B Ugt1a6b 5.6 NC 6.4 yes yes no
22235 UDP-glucose dehydrogenase Ugdh 2.7 2.5 2.7 yes yes yes
12491 CD36 antigen Cd36 5.7 NC 6.1 yes yes yes
26903 Dysferlin Dysfs 3.3 1.5 14.9 yes yes yes
170439 ELOVL family member 6, elongation of long chain fatty acids (yeast) Elovl6 −4.3 −3.8 −5.2 yes yes yes
Lipid and glucose metabolism 75497 Fatty acid binding protein 12 Fabp12 53.7 −1.5 34.4 yes yes yes
14104 Fatty acid synthase Fasn −4.3 −3.9 −6.4 yes yes yes
14718 Glutamate oxaloacetate transaminase 1, soluble Got1 −2.6 NC −4.3 yes yes yes
14571 Glycerol phosphate dehydrogenase 2, mitochondrial Gpd2 −3.0 1.5 −3.3 yes yes yes
72999 Insulin induced gene 2 Insig2 NC 5.9 4.0 yes yes yes
53357 Phospholipase A2, group VI Pla2g6 NC 2.5 1.8 yes yes yes
66350 Phospholipase A2, group XIIA Pla2g12as 3.7 2.7 7.7 yes yes yes
228026 Pyruvate dehydrogenase kinase, isoenzyme 1 Pdk1 −1.6 NC 1.6 yes yes no
20250 Stearoyl-Coenzyme A desaturase 2 Scd2 2.0 NC NC yes yes yes
20788 Sterol regulatory element binding factor 2 Srebf2 −1.7 −2.1 −1.6 yes yes yes
20787 Sterol regulatory element binding transcription factor 1 Srebf1 −2.3 −2.4 −4.6 yes yes yes
12125 BCL2-like 11 (apoptosis facilitator) Bcl2l11 1.9 NC 4.2 yes yes no
Cell cycle/Cell death 13197 Growth arrest and DNA-damage-inducible 45 alpha Gadd45a −3.6 9.4 3.1 yes no yes
17873 Growth arrest and DNA-damage-inducible 45 beta Gadd45b 5.7 10.8 29.2 yes yes yes
53415 HIV-1 tat interactive protein 2, homolog (human) Htatip2 3.5 NC 4.4 yes yes no
15937 Immediate early response 3 Ier3 3.5 NC 3.8 yes yes yes
17869 Myelocytomatosis oncogene Myc 3.0 4.2 7.2 yes yes yes
211323 Neuregulin 1 Nrg1 2.8 NC 6.7 yes yes yes
78688 Nucleolar protein 3 (apoptosis repressor with CARD domain) Nol3 NC 4.8 4.7 yes yes no
22033 Tnf receptor-associated factor 5 Traf5 2.1 NC 2.3 yes yes yes
21813 Transforming growth factor, beta receptor II Tgfbr2 1.6 1.8 2.4 yes yes yes
29820 Tumor necrosis factor receptor superfamily, member 19 Tnfrsf19 3.9 2.6 7.7 yes yes yes
21928 Tumor necrosis factor, alpha-induced protein 2 Tnfaip2 6.7 NC 6.9 yes yes yes
66443 Tumor necrosis factor, alpha-induced protein 8-like 1 Tnfaip8l1 3.0 NC 4.1 yes yes yes
Immune response 12774 Chemokine (C-C motif) receptor 5 Ccr5 2.4 −1.6 NC no yes yes
56644 C-type lectin domain family 7, member a Clec7a 3.9 NC 2.9 yes yes yes
58239 Dexamethasone-induced transcript Dexi −1.9 −1.9 −4.3 yes yes no
14129 Fc receptor, IgG, high affinity I Fcgr1 2.4 NC 1.9 yes yes no
14969 Histocompatibility 2, class II antigen E beta H2-Eb1 7.8 NC 5.0 yes yes yes
14998 Histocompatibility 2, class II, locus DMa H2-DMa 4.0 NC 2.7 yes yes yes
14999 Histocompatibility 2, class II, locus Mb1 H2-DMb1 4.9 NC 3.2 yes yes yes
15900 Interferon regulatory factor 8 Irf8 3.1 NC 2.0 yes yes yes
16994 Lymphotoxin B Ltb 2.9 NC 2.3 yes yes yes
17304 Milk fat globule-EGF factor 8 protein Mfge8 4.6 NC 5.0 yes yes yes
20719 Serine (or cysteine) peptidase inhibitor, clade B, member 6a Serpinb6as 5.1 NC 11.0 yes yes yes
20208 Serum amyloid A 1 Saa1 3.4 NC 3.2 yes yes no
20209 Serum amyloid A 2 Saa2 3.2 NC 3.2 yes yes yes
20210 Serum amyloid A 3 Saa3 7.8 NC 3.5 yes yes no

NC - no change.

*

Maximum fold change on the microarray (|fold change| >1.5, P1(t) > 0.90).

a

Putative DNA response elements identified by computational searches (see Materials and Methods).

b

QRTPCR results. The Agilent microarray Cyp3a11 probe maps the 60-mer region between positions 1105 and 1164 of the Cyp3a11 gene, which is 2053 bp long, while Cyp3a11 primers (listed in a Supplementary Table 3) amplify the 119 bp fragment between 1701 and 1819 bp suggesting that both approaches amplify non-overlapping regions of the gene.

s

Synergistic response verified by non-linear logistic modeling of QRTPCR dose-response data.